InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
6
T+90 hit rate
0%
T+90 mean return
-17.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Bolzon Bradley J PhD, Director. Director active across 2 companies, notably CRISPR Therapeutics AG. In total, 10 filings have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €2.7m. Activity tracked since 11 June 2021. The latest transaction was filed on 19 July 2021 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations10 total
3,504 shares@ US$125.669313.9% of flowCommon SharesSEC:0000899243-21-029271
3,504 shares@ US$125.66930.0080% mcap13.9% of flowCommon SharesSEC:0000899243-21-029271:0
615,607 shares0Common SharesSEC:0000899243-21-026801:0
3,216 shares@ US$150.650315.2% of flowCommon SharesSEC:0000899243-21-026800
615,607 shares0Common SharesSEC:0000899243-21-026801
6,515,869 sharesCommon StockSEC:0000899243-21-026769
6,515,869 sharesCommon StockSEC:0000899243-21-026769:0
3,216 shares@ US$150.65030.0087% mcap15.2% of flowCommon SharesSEC:0000899243-21-026800:0
5,427 shares@ US$125.622520.9% of flowCommon SharesSEC:0000899243-21-023880
5,427 shares@ US$125.62250.012% mcap20.9% of flowCommon SharesSEC:0000899243-21-023880:0
10 of 10 declarations
About Bolzon Bradley J PhD
Bradley J. Bolzon, PhD, serves as a Director at CRISPR Therapeutics AG and Monte Rosa Therapeutics, Inc. He plays a key role in the governance of these companies and in shaping their strategy. His expertise in biotechnology is an asset to the board.
